Recent Winners


+180%
PLX
Alert Price: $0.36
High Price: $1.01
Results: 180% in 40 Days
+157%
OREX
Alert Price: $1.81
High Price: $4.65
Results: 157% in 36 Days
+133%
CGIX
Alert Price: $1.50
High Price: $3.50
Results: 133% in 85 Days
+91%
GBT
Alert Price: $15.85
High Price: $30
Results: 91% in 41 Days
+90%
LPTH
Alert Price: $1.40
High Price: $2.66
Results: 90% in 69 Days
+87%
ARIA
Alert Price: $12.72
High Price: $23.75
Results: 87% in 20 Days
+72%
TRR
Alert Price: $10.10
High Price: $17.38
Results: 72% in 51 Days
+64%
MBLY
Alert Price: $37.68
High Price: $61.73
Results: 64% in 67 Days
+58%
AAOI
Alert Price: $28.22
High Price: $44.46
Results: 58% in 60 Days
+58%
XGTI
Alert Price: $1.47
High Price: $2.32
Results: 58% in 29 Days
+55%
EXAS
Alert Price: $15.10
High Price: $23.40
Results: 55% in 37 Days
+47%
CPRX
Alert Price: $1.20
High Price: $1.76
Results: 47% in 60 Days
+45%
PTLA
Alert Price: $25.06
High Price: $36.40
Results: 45% in 67 Days
+44%
VRTX
Alert Price: $79.39
High Price: $114.06
Results: 44% in 51 Days
+38%
EDIT
Alert Price: $18.24
High Price: $25.09
Results: 38% in 55 Days
+36%
CYNO
Alert Price: $48.25
High Price: $65.90
Results: 36% in 28 Days
+35%
NKTR
Alert Price: $13.75
High Price: $18.50
Results: 35% in 51 Days
+32%
EBS
Alert Price: $27.22
High Price: $35.88
Results: 32% in 6 Days
+31%
ATVI
Alert Price: $37.05
High Price: $48.42
Results: 31% in 68 Days
+27%
ILMN
Alert Price: $134.56
High Price: $171.52
Results: 27% in 55 Days
+27%
ICHR
Alert Price: $13.40
High Price: $17.04
Results: 27% in 22 Days
+27%
QRVO
Alert Price: $55.67
High Price: $70.64
Results: 27% in 73 Days
+25%
WILN
Alert Price: $1.58
High Price: $1.98
Results: 25% in 72 Days
+25%
BMA
Alert Price: $70.05
High Price: $87.41
Results: 25% in 61 Days
+23%
CNAT
Alert Price: $4.43
High Price: $5.45
Results: 23% in 3 Days
+23%
PEIX
Alert Price: $8.30
High Price: $10.25
Results: 23% in 12 Days
+21%
KATE
Alert Price: $15.40
High Price: $18.67
Results: 21% in 11 Days
+20%
REPH
Alert Price: $6.89
High Price: $8.25
Results: 20% in 11 Days
+20%
GNRT
Alert Price: $4.49
High Price: $5.37
Results: 20% in 62 Days
+20%
SN
Alert Price: $11.24
High Price: $13.46
Results: 20% in 15 Days
+20%
DXCM
Alert Price: $63.23
High Price: $76.06
Results: 20% in 68 Days

Past results are not indicative of future profits. This table is accurate, though not every trade is represented.


Trading Lessons

Mainstream Financial News

Archives

Sell Broadcom For a 19% Win

April 16, 2017: Sell Broadcom for a 19% win in 84 days and congrats if you made money on the trade.

March 01, 2017: Broadcom Ltd reports Q1 EPS of $3.63 versus the $3.48 estimate. Revenue also beat coming in at $4.14 billion versus the $4.06 billion estimate.

CEO Hock Tan said, “We had a (Read More….)

Sell Global Blood Therapeutics For a Huge 91% Win!

March 4, 2017: Sell Global Blood Therapeutics for a monster 91% win in 41 days! Congratulations if you were able to make money on the trade.

January 4, 2017: JPMorgan Chase initiates coverage of biotechnology firm Global Blood Therapeutics with an Overweight rating and a price target of $25. JPMorgan thinks GBT440 is a (Read More….)

Zimmer Biomet Announces International Release of the Innovative Subchondroplasty Procedure

February 07, 2017: Zimmer Biomet announced today the international release of the Subchondroplasty (SCP) Procedure. The Company received CE Mark approval for the commercialization of its SCP Procedure to facilitate distribution in the European Union (EU) and other countries that recognize the CE Mark. Zimmer Biomet also received approval for distribution in Canada, Singapore, Malaysia (Read More….)

Centene Beats on Earnings and Revenue

February 7, 2017: Centene reports Q4 EPS of $1.19 versus the $1.12 estimate. Revenue also beat coming in at $11.9 billion versus the $10.9 billion estimate. Quarter-end at-risk managed care membership came in at 11.44 million versus 5.1 million last year representing an increase of 223% YoY, nice!

January 5, 2017: Centene Corporation announced (Read More….)

Ironwood Pharmaceuticals Reports Positive Top-Line Results from Phase III Linaclotide Trial

January 29, 2017: Astellas Pharma and Ironwood Pharmaceuticals announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint.

Linaclotide is approved in Japan as the first prescription treatment for adults with irritable bowel syndrome with constipation (IBS-C). Linaclotide is (Read More….)

Horizon Pharma Guides On Track To Deliver $2 Billion In Sales by 2020

January 10, 2017: In a JPM slide presentation, Horizon Pharma says it’s on track to deliver $2 billion in total net sales by 2020.

December 22, 2016: Horizon Pharma announces that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 13/610,580, entitled “Methods of (Read More….)

CalAtlantic Fitch Raises Rating One Notch to BB from BB-

December 6, 2016: Fitch raises the rating one notch to BB from BB- of CalAtlantic Group and set the outlook to Stable. The upgrade of CalAtlantic Group’s IDR to BB reflects the company’s execution of its business model in the current moderately recovering housing environment, its land policies, and geographic diversity. The upgrade is also (Read More….)

Stock Market Prediction News For Week of October 10 2016

About 156K new jobs were added in September. The consensus was for 168K. The pace of job creation has slowed since last year, along with the U.S. economy. Friday’s September payrolls report of 156K new jobs was spun by Fed Vice Chair Fischer, as a “goldilocks” number, not too hot, not too cold.

I removed (Read More….)

Desperate Bank Opens Millions Of Fake Accounts For Fees

Banks are so desperate for profits, because of ultra-low interest rates, that they are increasingly turning to fraud.

A whopping 5,300 Wells Fargo employees were fired for creating over 2 million phony “ghost” bank accounts, and then charging customers fees on those accounts. The phony accounts earned the bank unwarranted fees and allowed Wells Fargo (Read More….)

Deadly Parasitic Derivative Collapse Spreading Through Global Markets

Deutsche Bank may be on the verge of collapse. Last week Deutsche Bank reported Q2 2016 earnings of 20 million euros which is a 98% drop in earnings year-over-year.

In 2015, Deutsche Bank announced its first full year of loss since the 2008 recession.

Deutsche Bank’s stock is down -60% over the last year (Read More….)

Black Lives Matter Horror Coming To A City Near You

A Black Lives Matter protest is coming to a city near you. You should be afraid.

Civil unrest is on the rise in America. In Dallas, Texas last week, African-American snipers killed five Caucasian police officers protecting protesters at a Black Lives Matter rally.

The African-American gunmen were angry with how many Caucasian cops kill (Read More….)

Banks: Next Week Earnings Could Be Bad, Real Bad

As earnings season kicks off, banks are set to report next week for the quarter ending June 30, 2016. Banks revenue has been falling for years as I wrote about here.

We know that Brexit made the situation worse for banks, but that will not factor in until next quarter.

Below is an interactive chart (Read More….)

US Banking Collapse Of Confidence As Earnings Fall

As earnings fall across the banking sector, and SEC criminal charges rise, new signs are emerging of a US banking collapse that may be already underway.

One of the most shocking facts about Brexit was the massive panic selling in US banks. The average decline for the country’s six biggest banks was -7.59%. Apparently, banks (Read More….)